Physician profile
Paul Bloch
NPI 1548688674
$5,742.44
in general payments reported to CMS, 2019-2025
23 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $337 · 2021: $362 · 2023: $2,195 · 2024: $2,301 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,573 · Food and Beverage: $2,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,572.50 |
| Food and Beverage | $2,242.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,912.88 | 2020-2024 | Lumenis Pulse 120h, Rezum Generator |
| Procept Biorobotics Corporation | $1,838.12 | 2023-2025 | Aquabeam Robotic System |
| Teleflex LLC | $501.36 | 2023-2024 | Urolift |
| Astellas Pharma US INC | $349.64 | 2019-2023 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $235.87 | 2020-2024 | Erleada |
| Corcept Therapeutics | $161.65 | 2023-2024 | Korlym |
| Janssen Scientific Affairs, LLC | $126.11 | 2025 | Erleada |
| Cook Medical LLC | $118.11 | 2023 | Fiber Dust |
| Merck Sharp & Dohme LLC | $74.72 | 2019 | |
| Coloplast Corp | $51.26 | 2021 | |
| 180 Medical, INC. | $49.14 | 2019-2023 | |
| Agiliti Surgical, INC. | $42.48 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.98 | 2019-2020 | |
| Bluewind Medical | $38.60 | 2024 | Revi |
| Axonics, INC. | $35.12 | 2024 | Bulkamid, Axonics |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $31.77 | 2024 | Stravix |
| Pfizer INC. | $28.75 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $28.50 | 2020 | |
| Dendreon Pharmaceuticals LLC | $17.64 | 2020 | |
| Sumitomo Pharma America, INC. | $15.94 | 2023 | Orgovyx |
| Baxter Healthcare | $15.43 | 2020 | |
| Calyxo, INC. | $14.21 | 2025 | Cvac Aspiration System |
| Photocure INC | $14.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Bloch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.